P3 Health Partners Inc. (PIIIW)
P3 Health Partners Statistics
Share Statistics
P3 Health Partners has 5.56B shares outstanding. The number of shares has increased by 179.41% in one year.
Shares Outstanding | 5.56B |
Shares Change (YoY) | 179.41% |
Shares Change (QoQ) | -19.18% |
Owned by Institutions (%) | 3.72% |
Shares Floating | 3.12B |
Failed to Deliver (FTD) Shares | 17.22K |
FTD / Avg. Volume | 46.93% |
Short Selling Information
The latest short interest is 4.08K, so 0% of the outstanding shares have been sold short.
Short Interest | 4.08K |
Short % of Shares Out | 0% |
Short % of Float | 0% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.24 and the forward PE ratio is null. P3 Health Partners's PEG ratio is 0.
PE Ratio | -0.24 |
Forward PE | n/a |
PS Ratio | 0.02 |
Forward PS | 0.9 |
PB Ratio | 0.43 |
P/FCF Ratio | -0.3 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for P3 Health Partners.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 1.01.
Current Ratio | 0.37 |
Quick Ratio | 0.37 |
Debt / Equity | 1.01 |
Debt / EBITDA | -0.32 |
Debt / FCF | -0.69 |
Interest Coverage | -14.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $4.17M |
Profits Per Employee | $-377.36K |
Employee Count | 360 |
Asset Turnover | 1.92 |
Inventory Turnover | n/a |
Taxes
Income Tax | 4.39M |
Effective Tax Rate | -1.43% |
Stock Price Statistics
The stock price has increased by -84.59% in the last 52 weeks. The beta is 0.95, so P3 Health Partners's price volatility has been higher than the market average.
Beta | 0.95 |
52-Week Price Change | -84.59% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.07 |
Relative Strength Index (RSI) | 43.72 |
Average Volume (20 Days) | 36.69K |
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.5B and earned -135.85M in profits. Earnings per share was -0.94.
Revenue | 1.5B |
Gross Profit | 1.5B |
Operating Income | -320.66M |
Net Income | -135.85M |
EBITDA | -242.11M |
EBIT | -328.16M |
Earnings Per Share (EPS) | -0.94 |
Balance Sheet
The company has 38.82M in cash and 76.34M in debt, giving a net cash position of -37.52M.
Cash & Cash Equivalents | 38.82M |
Total Debt | 76.34M |
Net Cash | -37.52M |
Retained Earnings | -503.19M |
Total Assets | 783.42M |
Working Capital | -312.27M |
Cash Flow
In the last 12 months, operating cash flow was -110.13M and capital expenditures 0, giving a free cash flow of -110.13M.
Operating Cash Flow | -110.13M |
Capital Expenditures | 0 |
Free Cash Flow | -110.13M |
FCF Per Share | -0.76 |
Margins
Gross margin is 100%, with operating and profit margins of -21.37% and -9.05%.
Gross Margin | 100% |
Operating Margin | -21.37% |
Pretax Margin | -20.39% |
Profit Margin | -9.05% |
EBITDA Margin | -16.14% |
EBIT Margin | -21.37% |
FCF Margin | -7.34% |
Dividends & Yields
PIIIW does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PIIIW.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -0.6 |
Piotroski F-Score | 3 |